Loading...
XKRX
002210
Market cap15mUSD
Jun 24, Last price  
973.00KRW
Name

Dongsung Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:002210 chart
P/E
P/S
0.27
EPS
Div Yield, %
Shrs. gr., 5y
-0.52%
Rev. gr., 5y
-0.14%
Revenues
87.17b
-1.45%
60,319,470,00062,231,434,00068,724,160,00071,926,026,00078,442,097,85084,581,021,13075,175,284,43073,157,941,99074,660,371,33079,720,854,99082,385,233,76091,912,685,72086,536,755,32087,799,927,10084,407,657,78093,328,194,83088,593,588,70088,448,234,00087,168,895,000
Net income
-25.74b
L+254.85%
2,655,952,0003,656,617,000568,431,000-7,937,344,0001,701,094,0003,192,087,640-1,988,228,680-10,946,949,990454,837,700-1,660,443,190-198,264,210-5,744,557,940-8,385,204,520-14,079,137,960-4,312,832,260-2,121,670,410-2,073,909,512-7,253,006,000-25,737,002,000
CFO
-12.86b
L+29.34%
2,917,321,000-365,261,000-5,020,962,0004,634,814,000-2,643,336,7802,804,608,550-2,567,516,7203,650,150,210-9,319,457,650-3,344,347,6101,798,768,5501,393,269,480-8,305,940,9005,009,717,510-2,751,533,010-3,882,625,680-4,293,334,675-9,943,022,000-12,860,398,000
Dividend
Dec 27, 201330 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
IPO date
Jan 19, 1990
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT